Development of an HPLC stability-indicating assay for 1-(2-thienylethyl)-4- imidazoline-2-thione

Journal of Liquid Chromatography and Related Technologies

Volumn 27, Issue 14, 2004, Pages 2189-2199

  B'Hymer, C ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Basic drug analysis; HPLC; Stability indicating assay; Zorbax Rx C8 column

Indexed keywords

COMPOSITION; HIGH TEMPERATURE EFFECTS; HYDROGEN PEROXIDE; MONITORING; PH; SODIUM COMPOUNDS; SOLUTIONS; ULTRAVIOLET DETECTORS;

BULK COMPOUNDS; MOBILE PHASE; SODIUM PHOSPHATE BUFFERS;

LIQUID CHROMATOGRAPHY;

1 (2 THIENYLETHYL) 4 IMIDAZOLINE 2 THIONE; BUFFER; HYDROGEN PEROXIDE; IMIDAZOLINE DERIVATIVE; SODIUM DIHYDROGEN PHOSPHATE; UNCLASSIFIED DRUG;

ACIDITY; ALKALINITY; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ARTICLE; CHEMICAL ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH TEMPERATURE; OXIDATIVE STRESS; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

EID: 4444368791     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-200025701     Document Type: Article

References (22)

1. Bakshi, M.; Singh, S. Development of validated stability-indicating assay methods - critical review. J. Pharma. Biomed. Anal. 2002, 28, 1011-1040.
2. Micheel, A.P.; Ko, C.Y.; Guh, H.Y. Ion chromatography method and validation for the determination of sulfate and sulfamate ions in topiramate drug substance and finished product. J. Chromatogr. B 1998, 709, 166-172.
3. Gadkareim, E.A.; Belal, F.; Abounassif, M.A.; El-Obeid, H.A.; Ibrahim, K.E.E. Photodegradation kinetic studies and stability-indicating assay of diloxanide furoate in dosage forms using high-performance liquid chromatography. J. Liq. Chromatogr. Relat. Technol. 2002, 25 (19), 2947-2964.
4. Bakshi, M.; Singh, B.; Singh, A.; Singh, S. The ICH guidance in practice: stress degradation studies on ormidazole and development of a validated stability-indicating assay. J. Pharm. Biomed. Anal. 2001, 26, 891-897.
5. The Federal Register. International conference on harmonisation; final guidelines on stability testing of biotechnological/biological products; availability. 1996, 61 (133), 36,466-36,469.
6. Kruse, L.I.; Kaiser, C.; DeWolf, W.E.; Frazee, J.S.; Garvey, E.; Hilbert, E.; Faulkner, W.A.; Flaim, K.E.; Sawyer, J.L.; Berkowitz, B.A. Multisubstrate inhibitors of dopamine beta-hydoxylase. Some 1-phenyl and 1-phenyl-bridged derivatives of imidaxole-2-thione. J. Med. Chem. 1986, 29, 2465-2472.
7. Kruse, L.I.; Kaiser, C.; DeWolf, W.E.; Frazee, J.S.; Erickson, R.W.; Ezekiel, M.; Ohlstein, E.H.; Ruffolo, R.R.; Berkowitz, B.A. Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of dopamine beta-hydroxylase. J. Med. Chem. 1986, 29, 887-889.
8. Kruse, L.I.; DeWolf, W.E.; Chambers, P.A.; Goodhart, P.J. Design and kinetic characterization of multisubstrate inhibitors of dopamine beta-hydroxylase. Biochemistry 1986, 25 (23), 7271-7278.
9. Levin, E.Y.; Levenberg, B.; Kaufman, S.J. The enzymatic conversion of 3,4-dihyroxyphenylethylamine to norepinephrine. Biol. Chem. 1960, 235, 2080-2086.
10. Kohler, J.; Kirkland, J.J. Improved silica-based column packings for high-performance liquid chromatography. J. Chromatogr. 1987, 385, 125-150.
11. Bayer, E.; Paulus, A. Silanophilic interactions in reversed-phase high-performance liquid chromatography. J. Chromatogr. 1987, 400, 1-4.
12. Stadalius, M.A.; Berus, J.S.; Snyder, L.R. Reversed-phase HPLC of basic samples. LC-GC 1988, 6 (6), 495-501.
13. Hill, D.W.; Kind, A.J. The effects of type B silica and triethylamine on the retention of drugs in silica based reverse phase high performance chromatography. J. Liq. Chromatogr. 1993, 16 (18), 3941-3964.
14. Hill, D.W. Evaluation of alkyl bonded silica and solvent phase modifiers for the efficient elution of basic drugs on HPLC. J. Liq. Chromatogr. 1990, 13 (16), 3147-3175.
15. Vervoort, R.J.M.; Derksen, N.W.J.; Maris, F.A. Selection of stationary phases for the liquid chromatographic analysis of basic compounds using chemometric methods. J. Chromatogr. A 1994, 678 (1), 1-15.
16. Bauer, J.F.; Krough, S.K.; Chang, Z.L.; Wong, C.F. Determination of minor impurities in terazosin hydrochloride by high performance liquid chromatography. J. Chromatogr. 1993, 648 (1), 175-181.
17. Golich, T.G.; Thomsen, J.R.; Green, D.L.; Jersild, J. Determination of minor impurities of (R)-1-acetoxymethyl-3-(7-[1-N,N-dimethylcarbanoxyl]-6-(4- fluorophenyl)-indol-3-oyl)-iH, 3H-pyrolo[1,2-c]thiozol-3-yl) pryidinium chloride by high performance liquid chromatography. J. Liq. Chromatogr. 1995, 18 (20), 4107-4116.
18. Maniara, W.M.; Cipriano, A.; Powell, M.L. Quantitative analytical methods for the determination of a new hypertension drug, CGS 25462, and its metabolites (CGS 25659 and CGS 24592) in human plasma by high performance liquid chromatography. J. Chromatogr. B 1998, 706 (2), 287-294.
19. Lin, C.C.; Matuszewski, B.K.; Zagrobelny, J.; Dobrinska, M.R. Picogram determination of an avermectin analog in dog plasma by high-performance liquid chromatography with fluorescence detection. J. Liq. Chromatogr. Relat. Technol. 1997, 20 (3), 443-458.
20. Agilent Zorbax Rx-C8 data sheet, Part no. 880968-001 D; Agilent Technologies: Palo Alto, California, 2002, 1-2.
21. B'Hymer, C. The development of a high performance liquid chromatographic test for impurities in 1-(2-thienylethyl)-4-imidazoline-2-thione. J. Liq. Chromatogr. Relat. Technol. 2003, 26 (4), 573-583.
22. Green, J.M. A practical guide to analytical method validation. Anal. Chem. 1996, 68, 305A-309A.